News

Valmet Partners with Sofidel America for Advanced Tissue Line

Valmet Partners with Sofidel America for Advanced Tissue Line

Valmet Enhances Sofidel America's Ultra-Premium Tissue Production

Valmet Oyj proudly announces its collaboration with Sofidel America to establish a sophisticated new tissue line designed to address the increasing demand for ultra-premium tissue products. This venture will enable Sofidel America to broaden its production capabilities substantially, meeting the needs of consumers across North America more effectively.

Investing in Advanced Technology

The installation of the Advantage ThruAir tissue line marks a significant investment from Sofidel, reflecting their commitment to quality and innovation in the market. Valmet's comprehensive supply consists of not just the tissue line but also an advanced automation package, flow control systems, and innovative Industrial Internet solutions that enhance production efficiency.

A Strong Partnership

Valmet and Sofidel America have enjoyed a collaborative relationship for over thirty years. Currently, Sofidel operates 20 tissue lines, demonstrating their extensive capacity to produce high-quality products. The latest project, an Advantage DCT line, was successfully launched at the company's Circleville mill in recent months, showcasing the effective teamwork and mutual trust between the two companies.

Meeting Growing Consumer Demand

Luigi Lazzareschi, CEO of Sofidel, expressed excitement about the new line, stating, “This significant investment anchors us deeper in the United States and enhances our capabilities to meet customer demands for premium tissue products. The Advantage ThruAir technology represents industry-leading standards in efficient production methods.” His remarks emphasize the expectation for continued success based on solid teamwork through their joint projects.

Technical Details of the New Line

The new tissue paper production line boasts a width of 5.6 meters with an impressive annual capacity of 75,000 tons. It has been specifically optimized to conserve fibers while delivering outstanding paper quality, meeting the high standards customers expect.

Comprehensive Delivery Scope

Valmet's order encompasses a complete range of services, including Mill Engineering and Stock preparation equipment. The cutting-edge Advantage ThruAir 200 tissue machine will play a crucial role in this project, backed by an automation package featuring the Valmet DNA Distributed Control System (DCS) and integrated machine condition monitoring.

Quality Control and Performance Monitoring

In addition, Valmet will provide a Quality Control System (QCS) and a Web Monitoring System (WMS) for enhancing product quality and ensuring optimal operational performance. The company's flow control and Industrial Internet solutions are also included, demonstrating Valmet's commitment to supporting its partners with top-tier technology endpoints.

About Sofidel Group

The Sofidel Group is a leading global manufacturer of paper for hygienic and domestic use. Established in 1966, the Group operates subsidiaries in 13 countries, employs over 9,500 staff, and achieved remarkable consolidated net sales figure in its latest financial reports. The company’s commitment to sustainability and innovation in production lines positions them at the forefront of the industry.

Operational Footprint

Sofidel America operates 14 production facilities, strategically located across various states, which enhances their distribution and response time to market demands. This operational spread illustrates Sofidel’s determination to maintain an efficient supply chain while ensuring customer satisfaction.

Continued Leadership and Innovation

Valmet is a well-respected global technology leader that serves diverse process industries. With a long history exceeding 225 years, they stand out in providing innovative technologies and services throughout various production lifecycles. Their dedication to sustainability and customer collaboration has established them as a trusted partner in numerous sectors.

Frequently Asked Questions

What is the new technology being introduced by Sofidel America?

The new technology being introduced is the Advantage ThruAir tissue line, aimed at enhancing production capabilities and meeting consumer demand for ultra-premium products.

How has Valmet contributed to this project?

Valmet is supplying the complete tissue production line, including advanced automation and quality control features, to significantly improve production efficiency.

What is the expected production capacity of the new line?

The new Advantage ThruAir tissue line is designed to produce an annual capacity of 75,000 tons of tissue paper.

What sets Sofidel America apart in the tissue market?

Sofidel America's extensive experience, dedication to sustainability, and innovative production techniques position them as a leader in the ultra-premium tissue market.

When is the new line scheduled to start operations?

The start-up of the new tissue line is planned for the second quarter of 2028, marking a pivotal moment for Sofidel America’s production capabilities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 144

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 78

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 110

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 150

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading

Top 5 Most Recently Viewed Articles

Vinanz Boosts Bitcoin Mining Operations with New Hardware

Updated Category News Views 160

Vinanz Limited Enhances Bitcoin Mining Capacity Vinanz Limited (US OTCQB: VINZF and AQSE: BTC) has taken a significant step forward in its operations by activating new Bitcoin mining hardware in Nebraska. This move aligns with its broader strategy to expand Bitcoin mining capabilities across North America. Introduction of Advanced Mining Technology The recent deployment...

Continue Reading
Recent Transparency Notification by Nyxoah - Key Insights

Updated Category News Views 202

Understanding Nyxoah's Recent Transparency Notification REGULATED INFORMATION Mont-Saint-Guibert – In alignment with disclosure requirements regarding shareholding changes, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an important transparency notification. Who is Vestal Point Capital? On October 23, Nyxoah disclosed that it received a transparency...

Continue Reading
Mural Oncology Set to Showcase Research at SITC Annual Meeting

Updated Category News Views 48

Mural Oncology Set to Showcase Research at SITC Annual Meeting Mural Oncology plc (NASDAQ: MURA), a pioneering company focused on immuno-oncology, is gearing up for a significant event—the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). This important gathering will take place from November 6-10, 2024, in Houston, Texas. Mural Oncology is excited...

Continue Reading
Genmab A/S Announces Share Buyback Progress and Strategy

Updated Category News Views 128

Overview of Genmab's Share Buyback Program Genmab A/S has initiated an impressive share buyback program aimed at enhancing shareholder value. The program, announced on March 25, is designed to repurchase up to 2.2 million shares as part of its strategy to reduce capital and fulfill commitments under the Restricted Stock Unit program. Recent Transactions Under the Buyback...

Continue Reading